The use of the peroxisome proliferator-activated receptors γ agonist rosiglitazone to treat airway hyperreactivity

Annals of Allergy, Asthma and Immunology

Volumn 109, Issue 1, 2012, Pages 75-77

  Sandhu, Manbir Singh ^a   Dimov, Vesselin ^a   Sandhu, Arveen Kaur ^a   Walters, Ryan W ^a   Wichman, Tammy ^a   Casale, Thomas ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHACHOLINE CHLORIDE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; ROSIGLITAZONE;

ADULT; AIRWAY HYPERACTIVITY; AIRWAY HYPERREACTIVITY; ASTHMA; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSIMETRY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; FRACTIONAL EXHALED OF NITRIC OXIDE; HUMAN; INHALATION TEST; LETTER; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT PARAMETERS; TREATMENT OUTCOME;

EID: 84862863756     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.05.001     Document Type: Article

References (11)

1. Benayoun L, Letuve S, Druilhe A, et al. Regulation of peroxisome proliferator-activated receptor γ expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling.AmJ Respir Crit Care Med. 2001;164:1487-1494. (Pubitemid 33124032)
2. Lee KS, Kim SR, Park SJ, et al. Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kB and hypoxia-inducible factor 1-alpha in allergic airway disease of mice. J Allergy Clin Immunol 2006;118:120-127. (Pubitemid 43949584)
3. Hammad H, de Heer HJ, Soullie T, et al. Activation of peroxisome proliferator-activated receptor in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma.AmJ Pathol. 2004;164:263-271. (Pubitemid 38364610)
4. Kim SR, Lee KS, Park HS, et al. Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma. Mol Pharmacol. 2005;68:1568-1575.
5. Honda K, Marquillies P, Capron M, Dombrowicz D. Peroxisome proliferator-activated receptorgammais expressed in airways and inhibits features of airway remodeling in a mouse asthma model. J Allergy Clin Immunol. 2004;113:882-888. (Pubitemid 38608597)
6. Hashimoto Y, Nakahara K. Improvement of asthma after administration of pioglitazone. Diabetes Care. 2002;25:401.
7. Crapo RO, Casaburi R, Coates AL. Guidelines for methacholine and exercise challenge testing. Am J Respir Crit Care Med 2000;161:309-329. (Pubitemid 30055941)
8. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Methods for Studying Change and Event Occurrence. New York: Oxford University Press; 2003.
9. Mehta V, Stokes JR, Berro A, Romero FA, Casale TB. Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma. Ann Allergy Asthma Immunol. 2009;103:31-37.
10. Spears M, McSharry C, Thomson NC. Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease. Clin Exp Allergy. 2006;36:1494-1504. (Pubitemid 44902926)
11. Belvisi MG, Hele DJ. Peroxisome proliferator-activated receptors as novel targets in lung disease. Chest. 2008;134:152-157. (Pubitemid 352008777)